SCICLONE PHARMACEUTICALS INC Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
SCICLONE PHARMACEUTICALS INC reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $604.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-09.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2017-03-09
- SCICLONE PHARMACEUTICALS INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2016 was $604.00K, a 109.72% increase from fiscal 2015.
- SCICLONE PHARMACEUTICALS INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2015 was $288.00K, a 39.81% increase from fiscal 2014.
- SCICLONE PHARMACEUTICALS INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2014 was $206.00K, a 79.13% increase from fiscal 2013.
- SCICLONE PHARMACEUTICALS INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2013 was $115.00K.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|
| 2016-12-31 | $604.00K 10-K · filed 2017-03-09 |
| 2015-12-31 | $288.00K 10-K · filed 2017-03-09 |
| 2014-12-31 | $206.00K 10-K · filed 2017-03-09 |
| 2013-12-31 | $115.00K 10-K · filed 2016-03-11 |